Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
kevin.
Lithuania
- Vilnius, Vilniaus Apskritis
- 03/05/2022
- Series A
- $65,000,000
Unlocking open banking to disrupt payments
- Industry Financial Services
- Website https://www.kevin.eu/
- LinkedIn https://www.linkedin.com/company/kevineu/
Related People
Pavel SokolovasFounder
Lithuania -
Vilnius, Vilniaus,
Entrepreneur and Business Strategist with 15+ years of experience in growing businesses in CEE countries.
Having started my career in Automotive Sales, later I built up my experience in Energy Consulting and Finance.
My passion for FinTech inspired the idea of kevin., which today is a licensed payment institution supervised by the Bank of Lithuania & passported in all EEA. Since 2018, we are on a mission to unlock open banking to disrupt payments. Our company’s values include expertise, ambition, reliability and
ownership.
Today, as a COO of kevin. I cultivate the culture of ownership, as I believe this is the way to have engaged and dedicated team.
Besides my professional life, I am a passionate tennis player and I believe that healthy minds live in healthy bodies.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)